English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

It is well documented that black and Hispanic individuals are significantly overrepresented among individuals with human immunodeficiency virus (HIV) infection and/or AIDS in the United States. Equally concerning is the fact that black individuals who are infected with HIV, compared with their white counterparts, have a higher mortality rate and shorter time to death after HIV diagnosis. After the introduction of highly active antiretroviral therapy (HAART) in 1996, AIDSrelated mortality decreased significantly until 1998, at which point it leveled off, remaining essentially unchanged through 2005. The percentage of decrease was smallest for black individuals, particularly black women, who experienced a 44% decrease, compared with a 79% decrease among white men [1]. In 2007, 9436 black or Hispanic individuals died as a result of HIV-related disease; this is more than double the number of white individuals who died of such causes in the same year [2]. Eighty-four percent of white patients survived 136 months after

Paying the Price for Late Starts and Early Stops: Racial and Sex Disparities in HIV‐Related Mortality